Unknown

Dataset Information

0

Regulation of ATP levels in Escherichia coli using CRISPR interference for enhanced pinocembrin production.


ABSTRACT:

Background

Microbial biosynthesis of natural products holds promise for preclinical studies and treating diseases. For instance, pinocembrin is a natural flavonoid with important pharmacologic characteristics and is widely used in preclinical studies. However, high yield of natural products production is often limited by the intracellular cofactor level, including adenosine triphosphate (ATP). To address this challenge, tailored modification of ATP concentration in Escherichia coli was applied in efficient pinocembrin production.

Results

In the present study, a clustered regularly interspaced short palindromic repeats (CRISPR) interference system was performed for screening several ATP-related candidate genes, where metK and proB showed its potential to improve ATP level and increased pinocembrin production. Subsequently, the repression efficiency of metK and proB were optimized to achieve the appropriate levels of ATP and enhancing the pinocembrin production, which allowed the pinocembrin titer increased to 102.02 mg/L. Coupled with the malonyl-CoA engineering and optimization of culture and induction condition, a final pinocembrin titer of 165.31 mg/L was achieved, which is 10.2-fold higher than control strains.

Conclusions

Our results introduce a strategy to approach the efficient biosynthesis of pinocembrin via ATP level strengthen using CRISPR interference. Furthermore coupled with the malonyl-CoA engineering and induction condition have been optimized for pinocembrin production. The results and engineering strategies demonstrated here would hold promise for the ATP level improvement of other flavonoids by CRISPRi system, thereby facilitating other flavonoids production.

SUBMITTER: Tao S 

PROVIDER: S-EPMC6142380 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulation of ATP levels in Escherichia coli using CRISPR interference for enhanced pinocembrin production.

Tao Sha S   Qian Ying Y   Wang Xin X   Cao Weijia W   Ma Weichao W   Chen Kequan K   Ouyang Pingkai P  

Microbial cell factories 20180918 1


<h4>Background</h4>Microbial biosynthesis of natural products holds promise for preclinical studies and treating diseases. For instance, pinocembrin is a natural flavonoid with important pharmacologic characteristics and is widely used in preclinical studies. However, high yield of natural products production is often limited by the intracellular cofactor level, including adenosine triphosphate (ATP). To address this challenge, tailored modification of ATP concentration in Escherichia coli was a  ...[more]

Similar Datasets

| S-EPMC5009306 | biostudies-literature
| S-EPMC7470443 | biostudies-literature
| S-EPMC7818426 | biostudies-literature
| S-EPMC4555050 | biostudies-literature
| S-EPMC7038292 | biostudies-literature
2024-11-27 | GSE248472 | GEO
| S-EPMC6375631 | biostudies-literature
2020-09-15 | GSE157942 | GEO
| S-EPMC7644443 | biostudies-literature
| S-EPMC10804669 | biostudies-literature